著者名,論文名,雑誌名,ISSN,出版者名,出版日付,巻,号,ページ,URL,URL(DOI)
Tomoya Kawaguchi and Masahiko Ando and Kazuhiro Asami and Yoshio Okano and Masaaki Fukuda and Hideyuki Nakagawa and Hidenori Ibata and Toshiyuki Kozuki and Takeo Endo and Atsuhisa Tamura and Mitsuhiro Kamimura and Kazuhiro Sakamoto and Michihiro Yoshimi and Yoshifumi Soejima and Yoshio Tomizawa and Shun-ichi Isa and Minoru Takada and Hideo Saka and Akihito Kubo,Randomized Phase III Trial of Erlotinib Versus Docetaxel As Second- or Third-Line Therapy in Patients With Advanced Non–Small-Cell Lung Cancer: Docetaxel and Erlotinib Lung Cancer Trial (DELTA),Journal of Clinical Oncology,0732-183X,American Society of Clinical Oncology (ASCO),2014-06-20,32,18,1902-1908,https://cir.nii.ac.jp/crid/1360565168981596288,https://doi.org/10.1200/jco.2013.52.4694